In order to gain a mechanistic insight into the complex molecular events leading to the progression of premalignant oral lesions to cancer, in the present study we looked for the promoter region methylation status of MGMT and p16 genes in the blood and tissue samples of patients with premalignant oral lesions and OSCC. The gene discussed is MGMT; the disease is dysplastic oral keratinocyte.